Glycopyrrolate 0.2 MG/ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26FGZD8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,184
Award facts
- Contract value 100% obligated
- $1,183.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on May 11, 2026, with a ceiling value of $1,183.80 for glycopyrrolate 0.2 mg/mL vial 20 mL, with an ultimate completion date of May 12, 2026.
The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract. Place of performance is Park Ridge, Illinois. The order is priced on a firm fixed-price basis with no set-aside designation.
Quick answers
Who was awarded contract SPE2DR26FGZD8?
SPE2DR26FGZD8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 11, 2026.
How much is contract SPE2DR26FGZD8 worth?
The government has obligated $1,184 on SPE2DR26FGZD8.
Is contract SPE2DR26FGZD8 an order under another contract?
Yes. SPE2DR26FGZD8 is a delivery order under SPE2DR25D9648, an indefinite delivery contract.
Was contract SPE2DR26FGZD8 competed?
The extent of competition for SPE2DR26FGZD8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award